DASATINIB EFFICACY IN PATIENTS WITH IMATINIB-RESISTANT/-INTOLERANT CHRONIC MYELOID LEUKEMIA IN ACCELERATED PHASE: 24-MONTH DATA FROM START-A

被引：0
|
作者：
Rea, D. [1 ]
Dombret, H. [1 ]
Kim, D. W. [2 ]
Rosti, G. [3 ]
Roy, L. [4 ]
Garzon, F. T. [5 ]
Yuan, X. [5 ]
Cortes, J. [6 ]
Guilhot, F. [4 ]
机构：
[1] Hop St Louis, Paris, France
[2] Catholic Univ, St Marys Hosp, Seoul, South Korea
[3] Bologna Univ Hosp, Inst Seragnoli, Bologna, Italy
[4] CHU Poitiers, Poitiers, France
[5] Bristol Myers Squibb Co, Wallingford, CT USA
[6] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0982
引用
收藏
页码：391 / 391
页数：1
相关论文
共 50 条
  • [41] Dasatinib Treatment for Imatinib Resistant or Intolerant Patients with Chronic Myeloid Leukaemia
    Li, J.
    Xu, G.
    Yu, S.
    He, L.
    Guo, L.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (02) : 337 - 347
  • [42] Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation
    Rogers, G.
    Hoyle, M.
    Coon, J. Thompson
    Moxham, T.
    Liu, Z.
    Pitt, M.
    Stein, K.
    HEALTH TECHNOLOGY ASSESSMENT, 2012, 16 (22) : 1 - +
  • [43] Safety and Efficacy of Flumatinib in Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Imatinib
    Liu, Yuntao
    Yang, Yunfan
    Sun, Hui
    Meng, Li
    Lin, Hai
    Chen, Chunyan
    Hu, Jianda
    Shen, Xuliang
    Duan, Minghui
    Zhang, Yanli
    Abulaiti, Dilinazi
    Wang, Jinghua
    Zhu, Hongqian
    Hua, Luoming
    Leng, Qing
    Zhang, Chun
    Sun, Lili
    Li, Weiming
    Zhu, Huanling
    Liu, Bingcheng
    Wang, Jianxiang
    BLOOD, 2023, 142
  • [44] NILOTINIB INDUCES RAPID AND DURABLE RESPONSES WITH 24-MONTH MINIMUM FOLLOW-UP IN PATIENTS WITH IMATINIB-RESISTANT OR -INTOLERANT CHRONIC MYELOID LEUKEMIA IN BLAST CRISIS (CML-BC)
    Giles, F.
    Kantarjian, H.
    le Coutre, P.
    Baccarani, M.
    Blakesley, R.
    Gallagher, N.
    Gillis, K.
    Larson, R.
    Ottmann, O.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 469 - 469
  • [45] Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial
    Apperley, Jane F.
    Cortes, Jorge E.
    Kim, Dong-Wook
    Roy, Lydia
    Roboz, Gail J.
    Rosti, Gianantonio
    Bullorsky, Eduardo O.
    Abruzzese, Elisabetta
    Hochhaus, Andreas
    Heim, Dominik
    de Souza, Carmino A.
    Larson, Richard A.
    Lipton, Jeffrey H.
    Khoury, H. Jean
    Kim, Hyeoung-Joon
    Sillaber, Christian
    Hughes, Timothy P.
    Erben, Philipp
    Van Tornout, Jan
    Stone, Richard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) : 3472 - 3479
  • [46] Pharmacokinetics of nilotinib in imatinib-resistant/intolerant chronic myeloid leukemia patients on hemodialysis for chronic renal failure
    Onaka, Takashi
    Takahashi, Naoto
    Miura, Masatomo
    Yonezawa, Akihito
    Imada, Kazunori
    Sawada, Kenichi
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (04) : 451 - 451
  • [47] Management of imatinib-resistant patients with chronic myeloid leukemia
    Bhamidipati, Pavan Kumar
    Kantarjian, Hagop
    Cortes, Jorge
    Cornelison, A. Megan
    Jabbour, Elias
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (02) : 103 - 117
  • [48] SIX-YEAR FOLLOW-UP OF PATIENTS WITH IMATINIB-RESISTANT OR IMATINIB-INTOLERANT CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) RECEIVING DASATINIB
    Rea, D.
    Vellenga, E.
    Junghanss, C.
    Baccarani, M.
    Kantarjian, H.
    Lofgren, C.
    Dejardin, D.
    Hochhaus, A.
    HAEMATOLOGICA, 2012, 97 : 80 - 80
  • [49] BUDGET IMPACT ANALYSIS OF DASATINIB IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) IN BRAZIL
    Asano, E.
    Nita, M.
    Moellmann-Coelho, A.
    Rached, R.
    Donato, B.
    Rahal, E.
    VALUE IN HEALTH, 2009, 12 (07) : A262 - A262
  • [50] Five-year follow-up of patients with imatinib-resistant or - intolerant chronic-phase chronic myeloid leukemia (CML-CP) receiving dasatinib
    Shah, N. P.
    Cortes, J. E.
    Schiffer, C. A.
    Guilhot, F.
    Brummendorf, T. H.
    Chen, A. C.
    Healey, D.
    Lambert, A.
    Saglio, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345